Media Library
icon
-
ImagelockPublications / ImageNovartis Logo
Novartis corporate logo
-
ImagelockLeadership / ImageSteffen Lang, Ph.D.
President, Operations
Member of the Executive Committee
-
ImagelockLocations / ImageTables and chairs next to green space
-
ImagelockLocations / ImageGehry building from a distance
-
ImagelockLocations / ImageFrontal view of Gehry building
-
PDFlockDisease Awareness / Fact SheetEarly versus Advanced Breast Cancer List
Although breast cancer is one of the most visible and supported diseases in the world, the majority of public focus goes toward prevention, early detection and survival.
-
PDFlockDisease Awareness / Fact SheetRenal Cell Carcinoma (RCC) Fact Sheet
Renal Cell Carcinoma (RCC) is the most common type of kidney cancer and accounts for 90% of all cancerous kidney tumors.
-
PDFlockDisease Awareness / Fact SheetChronic Myeloid Leukemia Today and Tomorrow Visual Fact Sheet
Global survey of Chronic Myeloid Leukemia (CML) treaters across 9 countries and 4 continents suggests many physicians are ambitiously managing the disease despite its chronic nature.
-
PDFlockCorporate Responsibility / Fact SheetNovartis Access fact sheet
This fact sheet provides information on Novartis Access, a social business model that brings affordable treatments to patients suffering from chronic diseases in low- and lower-middle-income countries (LMICs).
-
PDFlockDisease Awareness / Fact SheetChagas Disease
Reimagining the fight against Chagas disease: Although Chagas disease was discovered more than a century ago, it remains a major public health challenge – and current tools to fight the disease are outdated and inadequate.
-
PDFlockDisease Awareness / Fact SheetMalaria
Novartis has been in the front ranks of a revolution in the treatment of malaria, launching the first fixed-dose artemisinin-based combination therapy (ACT) in 1999 and the first dispersible pediatric ACT developed in partnership with Medicines for Malaria Venture (MMV) in 2009.
-
PDFlockDisease Awareness / Fact SheetReimagining the management of sickle cell disease in Africa
Reimagining the management of sickle cell disease in Africa. Sickle cell disease is a hereditary and life-threatening condition that causes ongoing vascular damage and repeated injury to blood vessels and organs. This lifelong illness often takes an extreme emotional, physical, and financial toll on patients and their families.
Pagination
- ‹ Previous page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- › Next page